Last reviewed · How we verify
NCT04341233: ECAP
Enhanced Clinics for Patients Diagnosed With Ankylosing Spondylitis and Psoriatic Arthritis
trial in Spondylitis, Ankylosing. Withdrawn.
28 February 2022
Quick facts
| Lead sponsor | NHS Lothian |
|---|---|
| Status | Withdrawn |
| Study type | OBSERVATIONAL |
| Start date | 1 August 2020 |
| Primary completion | 28 February 2022 |
| Estimated completion | 28 February 2023 |
Conditions studied
- Spondylitis, Ankylosing — all drugs for Spondylitis, Ankylosing →
- Psoriatic Arthritis — all drugs for Psoriatic Arthritis →
Sponsor
NHS Lothian — full company profile →
Who can join
Eligibility, any sex, with Spondylitis, Ankylosing or Psoriatic Arthritis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The 19.5 months project will pilot the introduction of a hospital-based, nurse-led ankylosing spondylitis (AS) and psoriatic arthritis (PsA) service for patients being initiated on biologic therapy in NHS Lothian Edinburgh Western General Hospital. It is anticipated that this new model of care will improve: 1. The time from referral for biologic therapy to initiation of treatment with a biological therapy due to the dedicated nurse to see patients 2. The management and monitoring of AS and PsA patients post commencement of treatment , in line with The National Institute for Health and Care Excellence (NICE) guidelines
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04341233
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Spondylitis, Ankylosing
Currently open trials in the same condition.
- NCT06842316 — Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases · recruiting
- NCT05879419 — Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases · Phase 4 · active not recruiting
- NCT05647577 — The Relationship Between Inflammatory ARTritis and CArdiac DIseAse · active not recruiting
- NCT04731831 — Characterization of Immunogenicity of TNF Inhibitors in Arthritis Patients With Poorer Treatment Response. · recruiting
- NCT01422694 — Natural History and Development of Spondyloarthritis · recruiting
Other NHS Lothian trials
Trials by the same sponsor.
- NCT06117059 — The PRECISION Study: 3 Fractions of Prostate SBRT and RayPilot HypoCath Image Guidance · NA · recruiting
- NCT05290818 — Total Versus Robotic Assisted Unicompartmental Knee Replacement · NA · recruiting
- NCT06932978 — The Use of Smart Glasses for Environmental Controls · NA · completed
- NCT06212622 — Is the Rate of Early Mobilisation in Hip Fracture Patients Using Alfentanil Better Than Standard Opioid Analgesia? · completed
- NCT07049419 — The Impact of Environmental Controls on Mental Health · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04341233 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by NHS Lothian
- Last refreshed: 13 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04341233.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing